IP Library Granted Patent US 10,251,585
Granted Patent B2
US 10,251,585 · App. 15/138,008 · Granted Apr 9, 2019

Noninvasive multi-parameter patient monitor

Inventors: Ammar Al-Ali (San Juan Capistrano, CA); Joe E. Kiani (Laguna Niguel, CA)
Assignee: Cercacor Laboratories, Inc.
A61B5/1455A61B5/0022A61B5/0205A61B5/0261A61B5/0295A61B5/02416A61B5/1495A61B5/14532A61B5/14546A61B5/14551A61B5/14552A61B5/6815A61B5/6826A61B5/6829A61B5/6832A61B5/6838A61B5/7221A61B5/7246A61B5/7275A61B5/7278A61B5/742A61B5/7405A61B5/746A61B5/7475G06F19/00G06F19/3418A61B1/00A61B5/02427A61B2562/08A61B2562/085A61B2562/222Y10S439/909
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,251,585
App. No.
15/138,008
Filed
Apr 25, 2016
Granted
Apr 9, 2019
Kind
B2
Examiner
LU, SHIRLEY
Art Unit
2686
USPC
340/573.1
Abstract

Embodiments of the present disclosure include a handheld multi-parameter patient monitor capable of determining multiple physiological parameters from the output of a light sensitive detector capable of detecting light attenuated by body tissue. For example, in an embodiment, the monitor is capable of advantageously and accurately displaying one or more of pulse rate, plethysmograph data, perfusion quality, signal confidence, and values of blood constituents in body tissue, including for example, arterial carbon monoxide saturation (“HbCO”), methemoglobin saturation (“HbMet”), total hemoglobin (“Hbt”), arterial oxygen saturation (“SpO2”), fractional arterial oxygen saturation (“SpaO2”), or the like. In an embodiment, the monitor displays a line associated with a patient wellness level.

Claims (37)

1. A method, comprising:

processing one or more signals with one or more signal processors, said one or more signals responsive to attenuation of light by body tissue of a monitored patient;

noninvasively, electronically determining measured values of oxygen saturation and arterial carbon monoxide saturation, based at least in part on the processed one or more signals;

determining a dynamic oxygen saturation threshold for the oxygen saturation based at least in part on an arterial carbon monoxide saturation level, wherein the dynamic oxygen saturation threshold increases based at least in part on an increase in the arterial carbon monoxide saturation level; and

activating a caregiver alert associated with a display based at least in part on at least one measured value of the oxygen saturation satisfying the dynamic oxygen saturation threshold.

2. The method of claim 1 , wherein the caregiver alert comprises at least one of an LED activation, an alarm message, or an audible alarm.

3. The method of claim 1 , wherein the caregiver alert changes as measured values of the oxygen saturation move further from the dynamic oxygen saturation threshold.

4. The method of claim 1 , wherein said activating the caregiver alert comprises emphasizing on the display the measured values of the oxygen saturation.

5. The method of claim 1 , wherein said activating the caregiver alert further comprises at least one of altering a size of measured values of the oxygen saturation on the display or alternately displaying and removing from the display the measured values of the oxygen saturation.

6. The method of claim 1 , further comprising:

displaying on the display the at least one measured value of the oxygen saturation; and

displaying on the display a prediction indicator corresponding to the oxygen saturation, wherein the prediction indicator indicates a predicted trend of measured values of the oxygen saturation.

7. A patient monitor, comprising:

a sensor port configured to receive one or more signals from a sensor, wherein the one or more signals are responsive to attenuation of light by body tissue of a monitored patient; and

a processor in communication with the sensor port and configured to:

noninvasively, electronically determine measured values of oxygen saturation and arterial carbon monoxide saturation using the one or more signals received from the sensor;

determine a dynamic oxygen saturation threshold for the oxygen saturation based at least in part on an arterial carbon monoxide saturation level, wherein the dynamic oxygen saturation threshold increases based at least in part on an increase in the arterial carbon monoxide saturation level; and

activate a caregiver alert associated with a display based at least in part on at least one measured value of the oxygen saturation satisfying the dynamic oxygen saturation threshold.

8. The patient monitor of claim 7 , wherein the caregiver alert comprises an LED activation on the display.

9. The patient monitor of claim 7 , wherein the caregiver alert comprises at least one of an alarm message or an audible alarm.

10. The patient monitor of claim 7 , wherein the caregiver alert comprises emphasizing on the display measured values of the oxygen saturation.

11. The patient monitor of claim 7 , wherein the caregiver alert comprises at least one of an altered size of measured values of the oxygen saturation on the display or an alternating display and removal from the display of the measured values of the oxygen saturation.

12. The patient monitor of claim 7 , wherein the processor is further configured to cause the display to display thereon:

the at least one measured value of the oxygen saturation; and

a prediction indicator corresponding to the oxygen saturation, wherein the prediction indicator indicates a predicted trend of measured values of the oxygen saturation.

13. The patient monitor of claim 7 , wherein the processor is further configured to cause the display to display thereon a wellness qualitative indication indicative of a patient wellness level based at least in part on a combination of the measured values of the oxygen saturation and the arterial carbon monoxide saturation level.

14. A method comprising:

noninvasively, electronically determining measured values of a first blood constituent and a second blood constituent, wherein the determining is performed by processing one or more signals with one or more signal processors, said one or more signals responsive to attenuation of light by body tissue of a monitored patient;

determining a dynamic threshold for the first blood constituent based at least in part on a second blood constituent level, wherein the dynamic threshold increases based at least in part on an increase in the second blood constituent level; and

activating a caregiver alert associated with a display based at least in part on at least one measured value of the first blood constituent satisfying the dynamic threshold.

15. The method of claim 14 , wherein the caregiver alert comprises at least one of an LED activation, an alarm message, or an audible alarm.

16. The method of claim 14 , wherein the caregiver alert changes as measured values of the oxygen saturation move further from the dynamic threshold.

17. The method of claim 14 , wherein said activating the caregiver alert comprises emphasizing on the display the measured values of the first blood constituent.

18. The method of claim 14 , wherein said activating the caregiver alert comprises at least one of altering a size of measured values of the first blood constituent displayed on the display or alternately displaying and removing from display the measured values of the first blood constituent.

19. The method of claim 14 , further comprising:

displaying on the display the at least one measured value of the first blood constituent; and

displaying on the display a prediction indicator corresponding to the first blood constituent, wherein the prediction indicator indicates a predicted trend of measured values of the first blood constituent.

Assignments (3)
CHANGE OF NAME Recorded May 16, 2024
From: CERCACOR LABORATORIES, INC.
To: WILLOW LABORATORIES, INC.
Reel/Frame 067455/0298 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 14, 2020
From: AL-ALI, AMMAR; KIANI, JOE E.
To: MASIMO LABORATORIES, INC.
Reel/Frame 053201/0385 →
CHANGE OF NAME Recorded Jul 14, 2020
From: MASIMO LABORATORIES, INC.
To: CERCACOR LABORATORIES, INC.
Reel/Frame 053201/0823 →
Continuity (9)
Continuation 14557761 · Dec 2, 2014
Continuation 14076556 · Nov 11, 2013
Continuation 13412428 · Mar 5, 2012
Continuation 11366208 · Mar 1, 2006
Provisional Application 60657759 · Mar 1, 2005
Provisional Application 60657596 · Mar 1, 2005
Provisional Application 60657281 · Mar 1, 2005
Provisional Application 60657268 · Mar 1, 2005
Related Publication 20160310052A1 · Oct 27, 2016
Cited By (34)
US 1,132,251 US 12,193,813 US 12,193,849 US 12,207,419 US 12,211,617 US 12,230,393 US 12,230,396 US 12,232,905 US 12,238,489 US 12,257,022 US 12,257,183 US 12,302,426 US 12,318,175 US 12,318,229 US 12,329,548 US 12,343,108 US 12,367,973 US 12,374,843 US 12,383,194 US 12,394,285 US 12,402,843 US 12,408,869 US 12,440,171 US 12,484,844 US 12,495,968 US 12,514,503 US 12,521,039 US 12,541,293 US 12,592,009 US 12,609,013 US 12,611,117 US 12,635,921 US 12,648,718 US 12,714,369